Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
CNS Neurosci Ther ; 18(8): 683-90, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22742831

RESUMO

AIM: To investigate the effect of chronic H1-antihistamine treatment on seizure susceptibility after drug withdrawal in nonepileptic rats and to further study its relation to glutamine synthetase (GS), which is the key enzyme for glutamate metabolism and gamma aminobutyric acid (GABA) synthesis. METHODS: After drug withdrawal from a 2-week treatment with diphenhydramine or pyrilamine, seizure susceptibility was determined by amygdaloid kindling or pentylenetetrazol model; meanwhile, the GS expression or activity was analyzed. The glutamine, glutamate, and GABA contents were measured by high-performance liquid chromatography. RESULTS: Seizure susceptibility significantly increased in amygdaloid kindling and pentylenetetrazol model 10 days after drug withdrawal from a 2-week treatment with H1-antihistamines. Meanwhile, GS activity and expression in the cortex or hippocampus decreased simultaneously with a marked decline of glutamine and GABA content. Comparable inhibition of GS activity by methionine sulfoximine was also sufficient to increase the susceptibility, while supplementation with glutamine reversed the high susceptibility 10 days after diphenhydramine withdrawal. Moreover, the seizure susceptibility increased 10 days after diphenhydramine withdrawal in wild-type mice but not in histidine decarboxylase knockout mice, which lack histamine. CONCLUSIONS: Chronic H1-antihistamine treatment produces long-lasting increase in seizure susceptibility in nonepileptic rodents after drug withdrawal and its mechanism involves impairment of GS through blocking the action of histamine.


Assuntos
Glutamato-Amônia Ligase/metabolismo , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Convulsões/epidemiologia , Convulsões/etiologia , Síndrome de Abstinência a Substâncias/enzimologia , Síndrome de Abstinência a Substâncias/epidemiologia , Animais , Astrócitos/enzimologia , Astrócitos/fisiologia , Western Blotting , Cromatografia Líquida de Alta Pressão , Convulsivantes , Eletrochoque , Ácido Glutâmico/metabolismo , Glutamina/metabolismo , Histidina Descarboxilase/deficiência , Histidina Descarboxilase/genética , Imuno-Histoquímica , Excitação Neurológica , Masculino , Metionina Sulfoximina/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Pentilenotetrazol , Ratos , Ratos Sprague-Dawley , Convulsões/induzido quimicamente , Ácido gama-Aminobutírico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA